CS logo
small CS logo
St. Lukes Roosevelt Hospital

New York, New York, United States
Emergency care service in New York City, New York
1111 Amsterdam Ave, New York, NY 10025

About St. Lukes Roosevelt Hospital


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
St. Luke's-Roosevelt Hospital Center
20
Gilead Sciences
5
Icahn School of Medicine at Mount Sinai
5
Radiation Therapy Oncology Group
5
Alliance for Clinical Trials in Oncology
4
AstraZeneca
4
Beth Israel Medical Center
4
Glaxo Wellcome
4
SWOG Cancer Research Network
4
Biosense Webster, Inc.
2
Bristol-Myers Squibb
2
Total Rows: 81

Clinical Trials at St. Lukes Roosevelt Hospital


During the past decade, St. Lukes Roosevelt Hospital conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 38 clinical trials were completed, i.e. on average, 190% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 10 clinical trials were completed. i.e. 125% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years4422332211443311334410109922334400Started TrialsCompleted Trails20152016201720182019202020212022051015
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Randomized, Double-Blind Study of the Efficacy and Safety of Oral Ganciclovir for the Prevention of CMV Disease in People Infected With the Human Immunodeficiency Virus
Completed
700
Safety and Effectiveness of Adding Adefovir Dipivoxil and Nelfinavir to the Anti-HIV Therapy of HIV-Infected Children
Unknown status
36
A Multicenter, Double-Blind, Phase III, Adjuvant-Controlled Study of the Effect of 10 Units of HIV-1 Immunogen (Remune) Compared to Incomplete Freund's Adjuvant (IFA) Alone Every 12 Weeks on AIDS-Free Survival in Subjects With HIV Infection and CD4 T-Lymphocytes Between 300 and 549 Cells/microL Rega
Completed
3,000
A Comparison of Valganciclovir and Ganciclovir in the Treatment of Cytomegalovirus (CMV) of the Eyes
1997-01-01
2002-12-01
Completed
The Safety and Effectiveness of Zidovudine Plus Lamivudine, Used With and Without 1592U89, in HIV-1 Infected Children Who Have Taken Anti-HIV-1 Drugs
Completed
A Comparison of Two Triple-Drug Combinations in Patients Who Have Never Been Treated With Anti-HIV Drugs
1998-03-01
1999-09-01
Completed
A Study on the Safety and Effectiveness of Adefovir Dipivoxil in Combination With Anti-HIV Therapy (HAART) in HIV-Positive Patients
Completed
390
Effectiveness of an HIV Vaccine in HIV-Negative Adults in North America Who Are at Risk of HIV Infection
Completed
5,000

Rows per page:

1–100 of 136

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "St. Lukes Roosevelt Hospital" #1 sponsor was "St. Luke's-Roosevelt Hospital Center" with 20 trials, followed by "Gilead Sciences" with 5 trials sponsored, "Icahn School of Medicine at Mount Sinai" with 5 trials sponsored, "Radiation Therapy Oncology Group" with 5 trials sponsored and "Alliance for Clinical Trials in Oncology" with 5 trials sponsored. Other sponsors include 92 different institutions and companies that sponsored additional 81 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "St. Lukes Roosevelt Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 19 trials as a collaborator, "St. Luke's-Roosevelt Hospital Center" with 6 trials as a collaborator, "NRG Oncology" with 5 trials as a collaborator, "Cancer and Leukemia Group B" with 3 trials as a collaborator and "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 3 trials as a collaborator. Other collaborators include 83 different institutions and companies that were collaborators in the rest 83 trials.
Created with Highcharts 11.1.0Top Leading SponsorsSt. Luke's-RooseveltHospital Center: 20St. Luke's-RooseveltHospital Center: 20Gilead Sciences: 5Gilead Sciences: 5Icahn School ofMedicine at Mount Sinai:5Icahn School ofMedicine at Mount Sinai:5Radiation TherapyOncology Group: 5Radiation TherapyOncology Group: 5Alliance for ClinicalTrials in Oncology: 4Alliance for ClinicalTrials in Oncology: 4AstraZeneca: 4AstraZeneca: 4Beth Israel Medical Center: 4Beth Israel Medical Center: 4Glaxo Wellcome: 4Glaxo Wellcome: 4SWOG Cancer ResearchNetwork: 4SWOG Cancer ResearchNetwork: 4Biosense Webster, Inc.: 2Biosense Webster, Inc.: 2

Created with Highcharts 11.1.0Top CollaboratorsNational CancerInstitute (NCI): 19National CancerInstitute (NCI): 19St. Luke's-RooseveltHospital Center: 6St. Luke's-RooseveltHospital Center: 6NRG Oncology: 5NRG Oncology: 5Cancer and LeukemiaGroup B: 3Cancer and LeukemiaGroup B: 3Eunice Kennedy ShriverNational Institute ofChild Health and HumanDevelopment (NICHD): 3Eunice Kennedy ShriverNational Institute ofChild Health and HumanDevelopment (NICHD): 3National Heart, Lung,and Blood Institute(NHLBI): 3National Heart, Lung,and Blood Institute(NHLBI): 3Bristol-Myers Squibb: 2Bristol-Myers Squibb: 2Columbia University: 2Columbia University: 2Icahn School ofMedicine at Mount Sinai:2Icahn School ofMedicine at Mount Sinai:2Merck Sharp & Dohme LLC: 2Merck Sharp & Dohme LLC: 2

Clinical Trials Conditions at St. Lukes Roosevelt Hospital


According to Clinical.Site data, the most researched conditions in "St. Lukes Roosevelt Hospital" are "HIV Infections" (18 trials), "Breast Cancer" (7 trials), "Lung Cancer" (7 trials), "Obesity" (6 trials) and "Heart Failure" (5 trials). Many other conditions were trialed in "St. Lukes Roosevelt Hospital" in a lesser frequency.

Clinical Trials Intervention Types at St. Lukes Roosevelt Hospital


Most popular intervention types in "St. Lukes Roosevelt Hospital" are "Drug" (70 trials), "Procedure" (19 trials), "Device" (17 trials), "Biological" (14 trials) and "Other" (13 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (14 trials), "AC2993" (4 trials), "Lamivudine" (4 trials), "Nelfinavir mesylate" (4 trials) and "therapeutic conventional surgery" (4 trials). Other intervention names were less common.

Clinical Trials Genders at St. Lukes Roosevelt Hospital


The vast majority of trials in "St. Lukes Roosevelt Hospital" are 120 trials for "All" genders, 12 trials for "Female" genders and 4 trials for "Male" genders.

Clinical Trials Status at St. Lukes Roosevelt Hospital


Currently, there are NaN active trials in "St. Lukes Roosevelt Hospital". 1 are not yet recruiting, 5 are recruiting, 11 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 89 completed trials in St. Lukes Roosevelt Hospital, undefined suspended trials, and 14 terminated clinical trials to date.
Out of the total trials that were conducted in St. Lukes Roosevelt Hospital, 5 "Phase 1" clinical trials were conducted, 33 "Phase 2" clinical trials and 40 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 9 trials, and there were also 33 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 40Phase 3: 40Not Applicable: 33Not Applicable: 33Phase 2: 33Phase 2: 33Phase 4: 9Phase 4: 9Phase 1: 5Phase 1: 5Early Phase 1: 1Early Phase 1: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 89Completed: 89Terminated: 14Terminated: 14Unknown status: 12Unknown status: 12Active, not recruiting: 11Active, not recruiting: 11Recruiting: 5Recruiting: 5Withdrawn: 4Withdrawn: 4Not yet recruiting: 1Not yet recruiting: 1